Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Stomach Neoplasms 6Neoplasms 2Lymphoma, Non-Hodgkin 2Helicobacter Infections 2Gastroesophageal Reflux 2Breast Neoplasms 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Erosive Reflux Disease 1Neoplasm Metastasis 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hemorrhage 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis, Atrophic 1Fatigue 1Familial primary gastric lymphoma 1Esophageal Neoplasms 1Delayed Bleeding 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Proton Pump Inhibitors × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT02609386 2024-01-30

INSPIRE

Brooklyn ImmunoTherapeutics, LLC

Phase 2 Completed
105 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡